surmount-1 tirzepatide 15 mg weight loss percent Adults with obesity using maintain 'remarkable' at 88 weeks Tirzepatide: In the SURMOUNT-1 trial,

From the beginning, we tailor your dosing schedule to fit your unique response and tolerance, ensuring you receive the most effective and comfortable treatment possible

Find out if d-limonene can help fight cancer or help for GERD (gastroesophageal reflux disorder), including evidence from clinical studies

(Table 1)

Covers the 15 August 2025 FDA approval of Tonix Pharmaceuticals' Tonmya (TNX-102 SL sublingual cyclobenzaprine) - the first new Read the full review Neuroscience 1 May 2026 Dihexa for Multiple Sclerosis (MS): Cognitive Impairment, Remyelination & the 2026 UK Review Can Dihexa help MS cognitive impairment or remyelination

Maintaining a robust antioxidant defense system is essential for supporting cellular health for both the mother and the baby